I. Mantel

Discipline

Psychology (13) History, Philosophy and Sociology of Sciences (1)

Type

Articles (31)

Co-author

Date

Source

Keyword

Patients (26) Patients (26) Treatment (21) Retinal degeneration (21) Eye (21) Retinal (Visual pigment) (18) Human beings (15) Injections (15) Visual acuity (14) Optical coherence tomography (14) Neovascularization (12) Months (12) Growth (12) Growth (12) therapy (11) Therapeutics (11) Older people (11) disease (10) Tomography (10) Tomography (10) disease (10) time (9) age (9) Time (9) Epithelium (9) Age (9) Age (9) Imaging (9) Rhodopsin (8) Manufacturers' agents (8)

Documents written by I. Mantel (31) | is about I. Mantel (0)

High-resolution adaptive optics-trans-scleral flood illumination (AO-TFI) imaging of retinal pigment epithelium (RPE) in central serous chorioretinopathy (CSCR).
V. Govindahari et al. (Jun 13, 2024)
Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration.
A. Gigon et al.
High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
E. Bousquet et al.
In Vivo Retinal Pigment Epithelium Imaging using Transscleral Optical Imaging in Healthy Eyes.
L. Kowalczuk et al.
Automated foveal location detection on spectral-domain optical coherence tomography in geographic atrophy patients.
A. Montesel et al.
TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration.
A. Montesel et al. (Apr 1, 2022)
Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.
E. Bousquet et al. (Mar 19, 2022)
Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study.
A. Gigon et al. (Mar 8, 2022)
Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.
E. Moret et al.
Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomography.
Y. Derradji et al. (Nov 8, 2021)
Personalized Atrophy Risk Mapping in Age-Related Macular Degeneration.
A. Gigon et al. (Nov 1, 2021)
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatment.
M. Zola et al.
Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning.
I. Mantel et al. (Apr 1, 2021)
Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration.
L.M. Marquis et al.
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment.
I. Mantel et al. (2020)
Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.
I. Mantel et al.
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen.
I. Mantel et al.
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.
M. Zhao et al. (Jan 21, 2019)
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance.
A. Dirani et al. (2018)
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.
L. Kowalczuk et al.
Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept.
P. Parvin et al.
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
A. Daruich et al.
Optimizing the Anti-VEGF Treatment Strategy for Neovascular Age-Related Macular Degeneration: From Clinical Trials to Real-Life Requirements.
I. Mantel (2015)
Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature.
A. Dirani et al. (2014)
Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen.
I. Mantel et al. (2014)

next